www.fdanews.com/articles/133910-alexion-buys-taligen-for-111-million
Alexion Buys Taligen for $111 Million
February 1, 2011
Cheshire, CT-based Alexion Pharmaceuticals has bought Cambridge, MA, biotech startup [Taligen] for $111 million and potential future payments, the buyer said Tuesday.
Xconomy
Xconomy